Tavin EM Tablet
Prescription Required
Marketed By
emcure
Pack of
30 tablets
Salt Composition
Tenofovir Disoproxil Fumarate and Emtricitabine
Storage
Keep in cold place
Delivering To: —
Overview
Tavin EM Tablet is an antiretroviral medication. It is used for the treatment of infection caused by HIV (human immunodeficiency virus). This medication helps to delay the production of HIV infection and improves the quality of life. Tavin EM tablet boosts your immune system to fight against infection and prevents the virus from multiplying. It increases the CD4 cell (white blood cells that protect against infection) count in your blood. Do not take this medicine in the wrong way as it may lead to some serious side effects. If you experience any signs and symptoms while receiving this medicine, inform your doctor immediately.
Indication
HIV
Side Effects
Tavin EM Tablet shows some side effects. Some of the mild ones do not need any medical attention, and they go away as the body adapts to the medicine. It is important to consult your doctor if they persist for a longer time and are deteriorating your health.
Common side effects include:
Rash
Weight loss
Trouble sleeping
Loss of strength
Fatigue
Sore throat
Allergic reaction
Unusual tiredness
Poor concentration
Anxiety
Drowsiness
Muscle weakness
Abnormal dreams
Inform your doctor immediately if you experience any persistent or unusual side effects.
How To Use
The doctor determines the dosage and duration of treatment with Tavin EM Tablet as per the patient's health condition. This medicine should be taken orally at the same time every day. Take it as a whole and don't crush or chew the medicine. This tablet can be taken with or without food. It is advised to take this medicine after consulting your healthcare expert. It is advisable not to change your regular dosing schedule without taking suggestions from your doctor.
Safety Advice
Alcohol
unsafe
Avoid the consumption of alcohol while taking Tavin EM Tablet, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
consult your doctor
Tavin EM Tablet is safe for use during pregnancy if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
Breast Feeding
consult your doctor
Tavin EM Tabletis unsafe to use during breastfeeding as it may cause toxicity to the baby.
Driving
danger
Tavin EM Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
precaution
Consumption of Tavin EM Tablet should be avoided without informing the doctor if you have any kidney-related issues.
Liver
precaution
Tavin EM Tablet is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
Missed Doses
It is advisable not to miss a dose. If you miss a scheduled dose of Tavin-EM tablets, contact your doctor immediately.
FAQs
Tavin-EM tablet is an antiviral medication that prevents the human immunodeficiency virus (HIV) from multiplying in your body.
Some common side effects are:- Abnormal dreams, fatigue, sore throat, headache, nausea, taste change, stomach ache, diarrhea, fever, chills, blurred vision, weight loss, abnormal dreams, etc.
This medication helps to boost your immune system to fight against infection and also increases the CD4 cell (white blood cells that protect against infection) count in your blood.
It is important to take this medicine as prescribed by your doctor.
Follow your doctor’s advice about any restrictions on food and other activities.
Reference
1. Ogbuagu, O., Ruane, P. J., Podzamczer, D., Salazar, L. C., Henry, K., Asmuth, D. M., ... & Young, B. (2021). Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. The lancet HIV, 8(7), e397-e407.
2. Mayer, K. H., Molina, J. M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., ... & Hare, C. B. (2020). Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. The Lancet, 396(10246), 239-254.
3. Dando, T. M., & Wagstaff, A. J. (2004). Emtricitabine/tenofovir disoproxil fumarate. Drugs, 64(18), 2075-2082.
4. Fung, S., Kwan, P., Fabri, M., Horban, A., Pelemis, M., Hann, H. W., ... & Gane, E. (2014). Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology, 146(4), 980-988.
5. Glidden, D. V., Mulligan, K., McMahan, V., Anderson, P. L., Guanira, J., Chariyalertsak, S., ... & Grant, R. M. (2018). Metabolic effects of preexposure prophylaxis with coformulated tenofovir disoproxil fumarate and emtricitabine. Clinical Infectious Diseases, 67(3), 411-419.
Related Products
MARKETER DETAILS
emcure
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.